| Code | 2942F | ||||||||||
| MA number | 44/0084/26-S | ||||||||||
| Product Form: | tbl flm 28x160 mg (blis.Al/OPA/Al/PVC) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Sandoz GmbH, Austria | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | blister Al/OPA/Al/PVC | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 01.04.2026 |
| Validity: | 01.04.2031 |
| PIL: |
PIL_Enzalutamid Sandoz GmbH 160 mg_03_2026.pdf
|
| SPC: |
SPC_Enzalutamid Sandoz GmbH 160 mg_03_2026.pdf
|
| Safety feature | Yes |
| Data update: | 01.04.2026 |
